The kinin system-bradykinin: Biological effects and clinical implications. Multiple role of the kinin system-bradykinin

Hippokratia

Volumn 11, Issue 3, 2007, Pages 124-128

  Golias, Ch ^a   Charalabopoulos, A ^a   Stagikas, D ^a   Charalabopoulos, K A ^a   Batistatou, A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Bradykinin biology; Bradykinin manifestations; Kinin system

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYL 4 (2 PYRIDYLMETHOXY)QUINOLINE; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE; B 9958; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; CYTOKINE; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE 8 LEUCINE]; ICATIBANT; INTERLEUKIN 1BETA; IRBESARTAN; KININ; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; R 954; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANGIONEUROTIC EDEMA; ARTERY DILATATION; ASCITES; BLOOD PRESSURE REGULATION; BLOOD TRANSFUSION REACTION; BLOOD VESSEL PERMEABILITY; DISEASE MODEL; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; INFLAMMATION; LIVER CIRRHOSIS; MITOGENESIS; NONHUMAN; PANCREATITIS; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; VEIN DILATATION;

EID: 34547157593     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Agostoni A, Cugno M. The kinin system: biological mechanisms and clinical implications. Recenti Prog Med 2001 92:764-773
2. Blaukat A. Structure and signalling pathways of kinin receptors. Andrologia 2003; 35:17-23
3. Bascands JL, Schanstra JP, Couture R, Girolami JP. Bradykinin receptors: towards new pathophysiological roles. Med Sci 2003 ; 19:1093-1100
4. Wu J, Akaike T, Hayashida K, et al. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 2002;98:29-35
5. Howl J, Payne SJ. Bradykinin receptors as a therapeutic target. Expert Opin Ther Targets 2003;7:277-285
6. Campbell DJ. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Braz J Med Biol Res 2000;33:665-677
7. Higashida H, Streaty RA, Klee W, Niremberg M. Bradykinin activated transmembrane signals are coupled via No or Ni to production of inositol 1,4,5- triphosphate, a second messenger in NG 108-15 neuroblastoma - glioma hydrid cells. Proc Natl Acad Sci USA 1986; 83:942-946
8. Li Y, Sato T. Dual signaling via protein kinase C and phosphatidylinositol 3′-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J Mol Cell Cardiol 2001;33:2047-53
9. Yang CM, Chien CS, Wang CC, et al. Interleukin-1beta enhances bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine tracheal smooth-muscle cells: involvement of the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway. Biochem J 2001;354:439-46
10. Hsu YM, Chiu CT, Wang CC, et al. Tumour necrosis factoralpha enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells. Cell Signal 2001;13:633-43
11. Huang CD, Tliba O, Panettieri RA Jr, Amrani Y. Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003;28:330-338
12. Alric C, Pecher C, Cellier E, et al. Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin. Kidney Int 2002;62:412-421
13. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol 1999;277(2 Pt 1):C253-61
14. Hall JM. Bradykinin receptors. Gen Pharmacol 1997;28:1-6
15. Raidoo DM, Bhoola KD. Kinin receptors on human neurones. J Neuroimmunol 1997 ;77:39-44
16. Dean R, Maric C, Aldred GP, et al. Rat renomedullary interstitial cells possess bradykinin B2 receptors in vivo and in vitro. Clin Exp Pharmacol Physiol 1999;26:48-55
17. Shughrue PJ, Ky B, Austin CP. Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization study. J Comp Neurol 2003;465:372-384
18. Gabra BH, Couture R, Sirois P. Functional duality of kinin receptors in pathophysiology. Med Sci 2003;19:1101-1110
19. Duchene J, Schanstra J, Cellier E, Bascands JL, Girolami JP. 30 years: Happy birthday, GPCR. The bradykinin B2 receptor: an alternative and antiproliferative pathway. Nephrologie 2002;23:39-41
20. Regoli D, Jukic D, Gobeil F. Kinin B1 and B2 receptor antagonists and therapeutic perspectives. Therapie 1995;50:9-18
21. Altamura M, Meini S, Quartara L, Maggi CA. Nonpeptide antagonists for kinin receptors. Regul Pept 1999;80:13-26
22. Aramori I, Zenkoh J, Morikawa N, et al. Nonpeptide mimic of bradykinin with long-acting properties. Immunopharmacology 1999;45:185-190
23. Regoli D, Rizzi A, Perron SI, Gobeil F Jr. Classification of kinin receptors. Biol Chem 2001;382:31-5
24. Gama Landgraf R, Sirois P, Jancar S. Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists. Eur J Pharmacol 2003;460:75-83
25. Drube S, Liebmann C. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist. Br J Pharmacol 2000;131:1553-60
26. Yang CM, Chien CS, Ma YH, Hsiao LD, Lin CH, Wu C. Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells. J Biomed Sci 2003;10:208-218
27. Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000;2000:RE1
28. Velarde V, Ullian M.E, Morinelli T.A, Mayfield R.K, Jaffa A.A. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol Cell Physiol 1999;277:253-261
29. Wirth KJ, Heitsch H, Scholkens BA. Kinin receptor antagonists: unique probes in basic and clinical research. Can J Physiol Pharmacol 1995;73:797-804
30. Heitsch H. The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease. Expert Opin Investig Drugs 2003;12:759-770
31. Tschope C, Schultheiss HP, Walther T. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J Cardiovasc Pharmacol 2002;39:478-487
32. Tschope C, Spillmann F, Altmann C, et al. The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc Res 2004 ;61:559-569
33. Couture R, Harrison M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001;429):161-176